Latest Chlamydia trachomatis Stories
RnRMarketResearch.com adds "Schistosomiasis - Pipeline Review, H2 2014" to its store. This report provides an overview of the Schistosomiasis's therapeutic pipeline. DALLAS, Jan.
HPV mRNA positive and Ct/Ng negative controls reduce repeat molecular testing MILFORD, Mass., Aug.
Assays bring an innovative solution to microbiology and molecular labs BALTIMORE, July 28, 2014 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), (NYSE:
Investigators at the Institute for Genome Sciences at the University of Maryland School of Medicine have developed a new technique that can track the activity of a disease-causing microbe and the host cell response to that pathogen simultaneously.
A recent study posted in Nature Genetics explains that researchers have found that Chlamydia has been evolving differently than previously thought. The researchers used whole genome sequencing to find these results.
In a study released today in Nature Genetics, researchers have found that Chlamydia has evolved more actively than was previously thought.
A UCSF study shows a popular treatment for a potentially blinding eye infection is just as effective if given every six months versus annually.
A breakthrough in the study of chlamydia genetics could open the way to new treatments and the development of a vaccine for this sexually transmitted disease.
A weakened strain of Chlamydia trachomatis bacteria may be used as a vaccine to prevent or reduce the severity of trachoma, the world’s leading cause of infectious blindness, according to this study conducted on monkeys.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.